Literature DB >> 21225445

Guiding effective decisions: an interview with Matthew Segall, CEO of Optibrium. Interview by Wendy A. Warr.

Matthew Segall.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21225445     DOI: 10.1007/s10822-011-9411-7

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


× No keyword cloud information.
  4 in total

Review 1.  Overcoming psychological barriers to good discovery decisions.

Authors:  Andrew T Chadwick; Matthew D Segall
Journal:  Drug Discov Today       Date:  2010-05-27       Impact factor: 7.851

2.  Automatic QSAR modeling of ADME properties: blood-brain barrier penetration and aqueous solubility.

Authors:  Olga Obrezanova; Joelle M R Gola; Edmund J Champness; Matthew D Segall
Journal:  J Comput Aided Mol Des       Date:  2008-02-14       Impact factor: 3.686

3.  ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr.

Authors:  John Overington
Journal:  J Comput Aided Mol Des       Date:  2009-02-05       Impact factor: 3.686

4.  Drug Guru: a computer software program for drug design using medicinal chemistry rules.

Authors:  Kent D Stewart; Melisa Shiroda; Craig A James
Journal:  Bioorg Med Chem       Date:  2006-07-25       Impact factor: 3.641

  4 in total
  1 in total

1.  A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery.

Authors:  Ignacio Aliagas; Alberto Gobbi; Timothy Heffron; Man-Ling Lee; Daniel F Ortwine; Mark Zak; S Cyrus Khojasteh
Journal:  J Comput Aided Mol Des       Date:  2015-02-24       Impact factor: 3.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.